Methylgene, Inc.
Patents = 53
Forward Citations = 537
where 'Filed Patents' based on already Granted Patents
where 'Inventors Filed' based on already Granted Patents
119 inventors (with patents filed for the assignee):
MethylGene, Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of small molecule drugs for the treatment of cancer. Their innovative approach uses epigenetic modulation to target and inhibit abnormal gene expression involved in cancer proliferation. With a strong pipeline of potential therapeutics, MethylGene aims to make a significant impact in improving cancer patients' lives.
This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com